Who
Reid Alexander Waldman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Veradermics; Director, Achieve Life Sciences.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $14.6M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Feb 2026
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Code M | $42K3,452 at $12.19 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $1.2M11,527 at $106.72 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $2.7M25,234 at $107.53 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,452 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $3.0M27,490 at $108.45 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $328K3,000 at $109.38 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $28K249 at $111.28 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE Veradermicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,452 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Code M | $42K3,452 at $12.19 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $1.2M11,527 at $106.72 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $2.7M25,234 at $107.53 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $3.0M27,490 at $108.45 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $328K3,000 at $109.38 | filing |
| 17 Aug 2026filed 18 Aug 2026 | MANE VeradermicsBiotechnology | SEC FORM 4 Sold | $28K249 at $111.28 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.